Study Countries

Georgia’s national elimination programme achieved a 67% reduction in general-population RNA prevalence by 2021. Tanzania has a concentrated hepatitis C epidemic among people who inject drugs. Tanzania’s RNA testing still costs approximately US$70 out of pocket. The trial is being implemented in Armenia, Georgia, and Tanzania.